Sarepta Therapeutics, Inc.
DE ˙ DB ˙ US8036071004
13,84 € ↓ -0,08 (-0,57%)
2026-06-04
DEL PRIS
SecurityDE:AB3A / Sarepta Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership724,259 shares
Latest Disclosed Value $ 15,759,876
Northern Trust Corp reports 1.25% decrease in ownership of AB3A / Sarepta Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 724,259 shares of Sarepta Therapeutics, Inc. (DE:AB3A) valued at $13,018,556 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 733,430 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -1.25% during the quarter. The current value of the position is $10,023,745 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 724,259 -9,171 -1.25 15,760 -0.15 0.0004
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 733,430 94,650 14.82 15,783 28.22 0.0020
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 638,780 -120,773 -15.90 12,309 -5.23 0.0016
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 759,553 -10,264 -1.33 12,988 -73.56 0.0018
2025-05-13 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 769,817 -33,694 -4.19 49,130 -49.71 0.0073
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 803,511 147,874 22.55 97,699 19.32 0.0138
2024-11-13 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 655,637 -12,441 -1.86 81,883 -22.43 0.0134
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 668,078 237,255 55.07 105,556 89.26 0.0178
2024-05-14 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 430,823 -6,743 -1.54 55,774 32.18 0.0096
2024-02-13 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 437,566 12,143 2.85 42,194 -18.18 0.0076
2023-11-13 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 425,423 14,868 3.62 51,570 9.68 0.0100
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 410,555 10,136 2.53 47,017 -14.81 0.0090
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 400,419 8,793 2.25 55,190 8.76 0.0109
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 391,626 6,073 1.58 50,747 19.07 0.0106
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 385,553 2,526 0.66 42,619 48.44 0.0097
2022-08-12 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 383,027 -17,599 -4.39 28,711 -8.26 0.0061
2022-05-13 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 400,626 -5,545 -1.37 31,297 -14.44 0.0055
2022-02-08 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 406,171 13,744 3.50 36,577 0.79 0.0060
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 392,427 4,217 1.09 36,292 20.25 0.0064
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 388,210 -94,592 -19.59 30,180 -16.13 0.0053
2021-05-12 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 482,802 -7,995 -1.63 35,983 -57.00 0.0067
2021-02-11 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 490,797 2,672 0.55 83,674 22.07 0.0163
2020-11-16 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 488,125 10,982 2.30 68,548 -10.40 0.0150
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 477,143 16,316 3.54 76,505 69.72 0.0181
2020-05-14 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 460,827 22,486 5.13 45,078 -20.31 0.0129
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 438,341 2,606 0.60 56,564 72.35 0.0127
2019-11-13 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 435,735 100,157 29.85 32,819 -35.64 0.0079
2019-08-13 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 335,578 22,903 7.32 50,990 36.82 0.0121
2019-05-13 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 312,675 -5,612 -1.76 37,267 7.29 0.0092
2019-02-12 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 318,287 19,473 6.52 34,734 -28.03 0.0097
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 298,814 627 0.21 48,262 22.45 0.0118
2018-09-18 2018-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 298,187 -415,572 -58.22 39,415 -25.46 0.0100
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 302,224 -411,535 39,948
2018-05-09 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 713,759 -413 -0.06 52,881 33.08 0.0138
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 714,172 3,530 0.50 39,736 23.27 0.0101
2017-11-13 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 710,642 81,138 12.89 32,235 51.90 0.0084
2017-08-11 2017-06-30 13F SAREPTA THERAPEUTICS COM 803607100 629,504 20,680 3.40 21,221 17.76 0.0059
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 608,824 28,301 4.88 18,021 13.17 0.0052
2017-02-13 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 580,523 72,956 14.37 15,924 -48.91 0.0049
2016-11-09 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 507,567 2,930 0.58 31,170 223.91 0.0097
2016-08-12 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 504,637 -26,760 -5.04 9,623 -7.23 0.0031
2016-08-19 2016-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 531,397 15,330 2.97 10,373 -47.90 0.0034
2016-05-13 2016-03-31 13F SAREPTA THERAPEUTICS COM 803607100 531,397 10,373
2016-02-12 2015-12-31 13F SAREPTA THERAPEUTICS COM 803607100 516,067 46,953 10.01 19,910 32.18 0.0066
2015-11-12 2015-09-30 13F SAREPTA THERAPEUTICS COM 803607100 469,114 469,114 0.00 15,063 0.0050
2015-08-13 2015-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -450,905 -100.00 0 -100.00
2015-05-14 2015-03-31 13F SAREPTA THERAPEUTICS COM 803607100 450,905 6,352 1.43 5,988 -6.92 0.0018
2015-02-12 2014-12-31 13F SAREPTA THERAPEUTICS COM 803607100 444,553 -14,036 -3.06 6,433 -33.52 0.0019
2014-11-13 2014-09-30 13F SAREPTA THERAPEUTICS COM 803607100 458,589 -9,175 -1.96 9,676 -30.56 0.0030
2014-08-14 2014-06-30 13F SAREPTA THERAPEUTICS COM 803607100 467,764 -21,803 -4.45 13,935 18.44 0.0043
2014-05-14 2014-03-31 13F SAREPTA THERAPEUTICS COM 803607100 489,567 -46,208 -8.62 11,765 7.80 0.0037
2014-02-21 2013-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 535,775 56,969 11.90 10,914 -51.74 0.0035
2014-02-12 2013-12-31 13F SAREPTA THERAPEUTICS COM 803607100 535,775 10,914
2013-11-13 2013-09-30 13F SAREPTA THERAPEUTICS COM 803607100 478,806 271,471 130.93 22,614 186.76 0.0080
2013-08-09 2013-06-30 13F SAREPTA THERAPEUTICS COM 803607100 207,335 207,335 7,886 0.0029
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.